<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3061">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04351542</url>
  </required_header>
  <id_info>
    <org_study_id>AU09</org_study_id>
    <nct_id>NCT04351542</nct_id>
  </id_info>
  <brief_title>Ayurveda for Flu Like Illness During Covid-19 Outbreak</brief_title>
  <official_title>Ayurveda for Flu-like Illness During the Covid 19 Outbreak: Non Randomised Single-blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarogyam UK</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarogyam UK</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu
      like illness during the Covid 19 outbreak.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 6, 2020</start_date>
  <completion_date type="Actual">April 12, 2020</completion_date>
  <primary_completion_date type="Actual">April 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>Ayurveda care provide was blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time to achieve afebrile</measure>
    <time_frame>Change from baseline to 3rd and 7th-day</time_frame>
    <description>Time to bring down a fever (oral temperature &lt; 37.2 ÌŠC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of symptom score</measure>
    <time_frame>Change from baseline to 3rd and 7th day</time_frame>
    <description>Symptoms diary card completed twice daily from Day 0 to Day 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient reported improvement</measure>
    <time_frame>Change from baseline to 3rd and 7th-day</time_frame>
    <description>Patient reported improvement using 4 scale; 0-none, 1-weak, 2-medium, 3-strong</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Flu Like Illness</condition>
  <arm_group>
    <arm_group_label>Ayurveda Care Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individualised ayurveda treatment was given to participants based on individual constitution.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants followed the usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ayurveda</intervention_name>
    <description>Based on individual constitution (ayurveda based assessment) and symptoms an individual has, ayurveda herbal supplement and self managed practices were advised along with usual care recommendation.</description>
    <arm_group_label>Ayurveda Care Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Usual care recommended by National Health Services, self isolation, plenty fluid, rest and Paracetamol. During the Covid 19 outbreak, additional recommendation were followed given by health services.</description>
    <arm_group_label>Ayurveda Care Group</arm_group_label>
    <arm_group_label>Usual Care Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with fu like symptoms within 48 hours of onset during March2020

          -  Mild to moderate symptoms who were advised to self isolate at home for 7-14 days

          -  Flu like symptoms present at least one respiratory symptom (e.g. cough, nasal
             obstruction, sore throat) and at least one constitutional symptom other than fever
             (e.g. fatigue, headache, myalgias) of less than 48-hour duration

          -  Willing to consent and follow up

        Exclusion Criteria:

          -  Pregnant/lactating

               -  Participants with chronic pulmonary diseases or critical condition or already
                  developed severe respiratory distress

               -  Clinically malignancies, systemic infection, other medical or psychiatric
                  condition which places the subject at unacceptable risk to participate in the
                  study - Known hypersensitivity to any ayurveda herbal substances

          -  Severe symptoms of respiratory distress patients deemed to require intensive care
             immediately
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neha Sharma, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarogyam UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jaydeep Joshi, BAMS</last_name>
    <role>Study Director</role>
    <affiliation>Aarogyam UK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarogyam</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 14, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2020</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

